These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

555 related items for PubMed ID: 17667922

  • 1. The histone deacetylase inhibitor trichostatin A downregulates human MDR1 (ABCB1) gene expression by a transcription-dependent mechanism in a drug-resistant small cell lung carcinoma cell line model.
    El-Khoury V, Breuzard G, Fourré N, Dufer J.
    Br J Cancer; 2007 Aug 20; 97(4):562-73. PubMed ID: 17667922
    [Abstract] [Full Text] [Related]

  • 2. Effects of the histone deacetylase inhibitor trichostatin A on nuclear texture and c-jun gene expression in drug-sensitive and drug-resistant human H69 lung carcinoma cells.
    El-Khoury V, Gomez D, Liautaud-Roger F, Trussardi-Régnier A, Dufer J.
    Cytometry A; 2004 Dec 20; 62(2):109-17. PubMed ID: 15517561
    [Abstract] [Full Text] [Related]

  • 3. Differential modulation of nuclear texture, histone acetylation, and MDR1 gene expression in human drug-sensitive and -resistant OV1 cell lines.
    Yatouji S, El-Khoury V, Trentesaux C, Trussardi-Regnier A, Benabid R, Bontems F, Dufer J.
    Int J Oncol; 2007 Apr 20; 30(4):1003-9. PubMed ID: 17332941
    [Abstract] [Full Text] [Related]

  • 4. Coordinated changes in DNA methylation and histone modifications regulate silencing/derepression of luteinizing hormone receptor gene transcription.
    Zhang Y, Fatima N, Dufau ML.
    Mol Cell Biol; 2005 Sep 20; 25(18):7929-39. PubMed ID: 16135786
    [Abstract] [Full Text] [Related]

  • 5. Correlation between histone acetylation and expression of the MYO18B gene in human lung cancer cells.
    Tani M, Ito J, Nishioka M, Kohno T, Tachibana K, Shiraishi M, Takenoshita S, Yokota J.
    Genes Chromosomes Cancer; 2004 Jun 20; 40(2):146-51. PubMed ID: 15101048
    [Abstract] [Full Text] [Related]

  • 6. Epigenetic modulation of tumor suppressor CCAAT/enhancer binding protein alpha activity in lung cancer.
    Tada Y, Brena RM, Hackanson B, Morrison C, Otterson GA, Plass C.
    J Natl Cancer Inst; 2006 Mar 15; 98(6):396-406. PubMed ID: 16537832
    [Abstract] [Full Text] [Related]

  • 7. Histone modification in the TGFbetaRII gene promoter and its significance for responsiveness to HDAC inhibitor in lung cancer cell lines.
    Osada H, Tatematsu Y, Sugito N, Horio Y, Takahashi T.
    Mol Carcinog; 2005 Dec 15; 44(4):233-41. PubMed ID: 16163707
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of interleukin-1beta-induced cyclooxygenase 2 expression in human synovial fibroblasts by 15-deoxy-Delta12,14-prostaglandin J2 through a histone deacetylase-independent mechanism.
    Farrajota K, Cheng S, Martel-Pelletier J, Afif H, Pelletier JP, Li X, Ranger P, Fahmi H.
    Arthritis Rheum; 2005 Jan 15; 52(1):94-104. PubMed ID: 15641079
    [Abstract] [Full Text] [Related]

  • 9. [Regulation of histone acetylation on the expression of cell cycle-associated genes in human colon cancer cell lines].
    Chen YX, Fang JY, Lu J, Qiu DK.
    Zhonghua Yi Xue Za Zhi; 2004 Feb 17; 84(4):312-7. PubMed ID: 15059516
    [Abstract] [Full Text] [Related]

  • 10. Histone deacetylase inhibitor-induced cellular apoptosis involves stanniocalcin-1 activation.
    Law AY, Lai KP, Lui WC, Wan HT, Wong CK.
    Exp Cell Res; 2008 Oct 01; 314(16):2975-84. PubMed ID: 18652825
    [Abstract] [Full Text] [Related]

  • 11. Histone deacetylase inhibitor, Trichostatin A, activates p21WAF1/CIP1 expression through downregulation of c-myc and release of the repression of c-myc from the promoter in human cervical cancer cells.
    Li H, Wu X.
    Biochem Biophys Res Commun; 2004 Nov 12; 324(2):860-7. PubMed ID: 15474507
    [Abstract] [Full Text] [Related]

  • 12. Histone deacetylase inhibitors activate INK4d gene through Sp1 site in its promoter.
    Yokota T, Matsuzaki Y, Miyazawa K, Zindy F, Roussel MF, Sakai T.
    Oncogene; 2004 Jul 08; 23(31):5340-9. PubMed ID: 15107822
    [Abstract] [Full Text] [Related]

  • 13. E2F-HDAC complexes negatively regulate the tumor suppressor gene ARHI in breast cancer.
    Lu Z, Luo RZ, Peng H, Huang M, Nishmoto A, Hunt KK, Helin K, Liao WS, Yu Y.
    Oncogene; 2006 Jan 12; 25(2):230-9. PubMed ID: 16158053
    [Abstract] [Full Text] [Related]

  • 14. Requirement of a specific Sp1 site for histone deacetylase-mediated repression of transforming growth factor beta Type II receptor expression in human pancreatic cancer cells.
    Zhao S, Venkatasubbarao K, Li S, Freeman JW.
    Cancer Res; 2003 May 15; 63(10):2624-30. PubMed ID: 12750289
    [Abstract] [Full Text] [Related]

  • 15. Cyclin D1 gene activation in human myeloma cells is independent of DNA hypomethylation or histone hyperacetylation.
    Krieger S, Grunau C, Sabbah M, Sola B.
    Exp Hematol; 2005 Jun 15; 33(6):652-9. PubMed ID: 15911089
    [Abstract] [Full Text] [Related]

  • 16. Histone H3 acetylation is associated with reduced p21(WAF1/CIP1) expression by gastric carcinoma.
    Mitani Y, Oue N, Hamai Y, Aung PP, Matsumura S, Nakayama H, Kamata N, Yasui W.
    J Pathol; 2005 Jan 15; 205(1):65-73. PubMed ID: 15586362
    [Abstract] [Full Text] [Related]

  • 17. Trichostatin A and structurally related histone deacetylase inhibitors induce 5-lipoxygenase promoter activity.
    Klan N, Seuter S, Schnur N, Jung M, Steinhilber D.
    Biol Chem; 2003 May 15; 384(5):777-85. PubMed ID: 12817474
    [Abstract] [Full Text] [Related]

  • 18. Down-regulation of p300/CBP histone acetyltransferase activates a senescence checkpoint in human melanocytes.
    Bandyopadhyay D, Okan NA, Bales E, Nascimento L, Cole PA, Medrano EE.
    Cancer Res; 2002 Nov 01; 62(21):6231-9. PubMed ID: 12414652
    [Abstract] [Full Text] [Related]

  • 19. Differential sensitivity of human leukemic cell lines to the histone deacetylase inhibitor, trichostatin A.
    Ninios YP, Sekeri-Pataryas KE, Sourlingas TG.
    Leuk Res; 2010 Jun 01; 34(6):786-92. PubMed ID: 19782399
    [Abstract] [Full Text] [Related]

  • 20. Loss of NECL1, a novel tumor suppressor, can be restored in glioma by HDAC inhibitor-Trichostatin A through Sp1 binding site.
    Gao J, Chen T, Liu J, Liu W, Hu G, Guo X, Yin B, Gong Y, Zhao J, Qiang B, Yuan J, Peng X.
    Glia; 2009 Jul 01; 57(9):989-99. PubMed ID: 19062177
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.